Gliamed, Inc.
Records under this name other than patents Gliamed, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,362,160 | Immunophilin-binding agents prevent glutamate neurotoxicity associated with vascular stroke and neurodegenerative diseases Term ended Term ended Mar 26, 2019 · From the USPTO record | Term ended | Term ended Mar 26, 2019 | From the USPTO record |
| US 6,376,517 | Pipecolic acid derivatives for vision and memory disorders Formerly held Term ended Ended no later than Aug 14, 2018 · From the USPTO record | Term ended | Ended no later than Aug 14, 2018 | From the USPTO record |
| US 7,265,150 | Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds for vision and memory disorders Lapsed on the fee record Ended Sep 4, 2015 · From the USPTO record | Lapsed on the fee record | Ended Sep 4, 2015 | From the USPTO record |
| US 7,282,510 | Small Molecule Inhibitors of Rotamase Enzyme Activity Term ended Term ended Jun 7, 2015 · Medium confidence | Term ended | Term ended Jun 7, 2015 | Medium confidence |
| US 7,652,060 | Small molecule rotamase enzyme inhibitors Term ended Ended no later than Jun 7, 2015 · From the USPTO record | Term ended | Ended no later than Jun 7, 2015 | From the USPTO record |
| US 7,960,570 | Small molecule inhibitors of rotamase enzyme activity Term ended Term ended Jun 7, 2015 · From the USPTO record | Term ended | Term ended Jun 7, 2015 | From the USPTO record |
| US 6,500,843 | Inhibitors of rotamase enzyme activity Lapsed on the fee record Ended Dec 31, 2014 · From the USPTO record | Lapsed on the fee record | Ended Dec 31, 2014 | From the USPTO record |
| US 7,153,883 | Carboxylic Acids and Carboxylic Acid Isosteres of N-Heterocyclic Compounds Lapsed on the fee record Ended Dec 26, 2014 · Medium confidence | Lapsed on the fee record | Ended Dec 26, 2014 | Medium confidence |
| US 6,462,072 | Cyclic ester or amide derivatives Lapsed on the fee record Ended Oct 8, 2014 · From the USPTO record | Lapsed on the fee record | Ended Oct 8, 2014 | From the USPTO record |
| US 7,795,216 | Methods for Promoting Composite Tissue Regeneration and Uses Thereof Lapsed on the fee record Ended Sep 14, 2014 · High confidence | Lapsed on the fee record | Ended Sep 14, 2014 | High confidence |